Search
for
Sort by
Research 781–810 of 1000+
- Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male
- Traction alopecia: the root of the problem
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Skin Conditions in Figure Skaters, Ice-Hockey Players and Speed Skaters
- The effect of menopause on the skin and other connective tissues
- Deciphering the functions of the hair follicle infundibulum in skin physiology and disease
- Exogen hair characterization in human scalp
- Hair loss in elderly women
- Scalp Itch: A Systematic Review
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)
- Biochemistry of epidermal stem cells
- The dermatological consequences of obesity
- How much medication is delivered in a novel drug delivery technique that uses a tattoo machine?
- A review of cellular biopreservation considerations during hair transplantation
- Skin 3D Bioprinting. Applications in Cosmetology
- Review of factors affecting the growth and survival of follicular grafts.
- Management of hair loss diseases
- Biology of Human Hair: Know Your Hair to Control It
- Polycystic ovary syndrome: a dermatologic approach
- Inhalation therapy for repairing damaged elastin fibers and decelerating elastinolysis in chronic obstructive pulmonary disease
- Comprehensive Management of Eyebrow and Forehead Ptosis
- Skin health and integrity
- Skin eruptions specific to pregnancy: an overview
- Progress in Relevant Growth Factors Promoting the Growth of Hair Follicle
- PHARMACOGNOSTICAL EVALUATION OF ROOTS OF SIMMONDSIA CHINENSIS SCHNEIDER
- Problems in pattern alopecia
- Hair Loss and Hair Restoration in Women
- The hair growth promoting effect of 4-O-methylhonokiol
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER